Alan Young
Publications by Year
Research Areas
Asthma and respiratory diseases, Receptor Mechanisms and Signaling, Pharmacological Effects and Assays, Immune Response and Inflammation, Chronic Obstructive Pulmonary Disease (COPD) Research
Most-Cited Works
- → Differential Regulation of Cytokine Release and Leukocyte Migration by Lipopolysaccharide-Stimulated Primary Human Lung Alveolar Type II Epithelial Cells and Macrophages(2007)208 cited
- → Innate Immune Responses to Bacterial Ligands in the Peripheral Human Lung – Role of Alveolar Epithelial TLR Expression and Signalling(2011)87 cited
- → Primary Human Alveolar Type II Epithelial Cell CCL20 (Macrophage Inflammatory Protein-3α)–Induced Dendritic Cell Migration(2004)81 cited
- → QSAR and the Rational Design of Long-Acting Dual D2-Receptor/β2-Adrenoceptor Agonists(2003)63 cited
- → Dual D2-Receptor and β2-Adrenoceptor Agonists for the Treatment of Airway Diseases. 1. Discovery and Biological Evaluation of Some 7-(2-Aminoethyl)- 4-hydroxybenzothiazol-2(3H)-one Analogues(1998)51 cited
- → Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action(2014)25 cited
- → Design driven HtL: The discovery and synthesis of new high efficacy β2-agonists(2011)23 cited
- → Design-driven LO: The discovery of new ultra long acting dibasic β2-adrenoceptor agonists(2011)19 cited
- → From libraries to candidate: The discovery of new ultra long-acting dibasic β2-adrenoceptor agonists(2011)18 cited
- → Dual dopamine D2 receptor and β2-adrenoceptor agonists for the treatment of chronic obstructive pulmonary disease: the pre-clinical rationale(2003)15 cited